BST-236, a novel cytarabine prodrug for patients with acute...

Blood Advances 2019 / 11 Vol. 3; Iss. 22

BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study

Zuckerman, Tsila, Ram, Ron, Akria, Luiza, Koren-Michowitz, Maya, Hoffman, Ron, Henig, Israel, Lavi, Noa, Ofran, Yishai, Horowitz, Netanel A., Nudelman, Olga, Tavor, Sigal, Yeganeh, Shay, Gengrinovitch
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2019000468
Date:
November, 2019
File:
PDF, 975 KB
2019
Conversion to is in progress
Conversion to is failed